Enzo Biochem, Inc. (LON:0IHV)

Enzo Biochem Statistics

Total Valuation

Enzo Biochem has a market cap or net worth of GBP 27.09 million. The enterprise value is 2.15 million.

Market Cap	27.09M
Enterprise Value	2.15M

Important Dates

The last earnings date was Monday, October 13, 2025.

Earnings Date	Oct 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	52.35M
Shares Outstanding	n/a
Shares Change (YoY)	+3.46%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.31
PB Ratio	0.83
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.14
EV / Sales	0.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.18

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.07.

Current Ratio	2.84
Quick Ratio	2.41
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-57.26

Financial Efficiency

Return on equity (ROE) is -13.95% and return on invested capital (ROIC) is -11.49%.

Return on Equity (ROE)	-13.95%
Return on Assets (ROA)	-8.98%
Return on Invested Capital (ROIC)	-11.49%
Return on Capital Employed (ROCE)	-24.26%
Revenue Per Employee	157,296
Profits Per Employee	-120,700
Employee Count	136
Asset Turnover	0.35
Inventory Turnover	2.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.60% in the last 52 weeks. The beta is 0.96, so Enzo Biochem's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-39.60%
50-Day Moving Average	0.53
200-Day Moving Average	1.32
Relative Strength Index (RSI)	64.23
Average Volume (20 Days)	13,786

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.77

Income Statement

In the last 12 months, Enzo Biochem had revenue of GBP 20.61 million and -15.81 million in losses. Loss per share was -0.30.

Revenue	20.61M
Gross Profit	8.83M
Operating Income	-8.46M
Pretax Income	-5.88M
Net Income	-15.81M
EBITDA	-7.45M
EBIT	-8.46M
Loss Per Share	-0.30

Balance Sheet

The company has 27.52 million in cash and 2.25 million in debt, giving a net cash position of 25.27 million.

Cash & Cash Equivalents	27.52M
Total Debt	2.25M
Net Cash	25.27M
Net Cash Per Share	n/a
Equity (Book Value)	32.55M
Book Value Per Share	0.62
Working Capital	23.45M

Cash Flow

In the last 12 months, operating cash flow was -11.49 million and capital expenditures -770,260, giving a free cash flow of -12.26 million.

Operating Cash Flow	-11.49M
Capital Expenditures	-770,260
Free Cash Flow	-12.26M
FCF Per Share	n/a

Margins

Gross margin is 42.83%, with operating and profit margins of -41.06% and -76.73%.

Gross Margin	42.83%
Operating Margin	-41.06%
Pretax Margin	-28.54%
Profit Margin	-76.73%
EBITDA Margin	-36.13%
EBIT Margin	-41.06%
FCF Margin	n/a

Dividends & Yields

Enzo Biochem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-3.46%
Shareholder Yield	n/a
Earnings Yield	-58.36%
FCF Yield	-45.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Enzo Biochem has an Altman Z-Score of -4.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.84
Piotroski F-Score	2